{"url_path":"/sec/anip/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000050-index.html","accession_number":"0001023024-26-000050","cik":"0001023024","ticker":"ANIP","issuer_name":"ANI PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000050-index.html","primary_entity_key":"0001023024","primary_entity_name":"ANI PHARMACEUTICALS INC"},"word_count":138,"has_tables":true,"body_markdown":"Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds\n\nSales of Unregistered Securities\n\nNone.\n\nIssuer Purchases of Equity Securities\n\nThere were no repurchases of equity securities pursuant to a repurchase plan or program during the three months ended March 31, 2026.\n\nPeriod\nTotal Number\n\nof Shares\n\nPurchased (1)\nAverage Price\nPaid per ShareTotal Number of\nShares Purchased as\nPart of Publicly\nAnnounced Plans or\nProgramsMaximum Number (or\napproximate dollar\nvalue) of Shares\nthat may yet be\nPurchased Under the\nPlans or Programs\n\nJanuary 1 - January 31, 20263,004 $85.29 —$— \n\nFebruary 1 - February 28, 2026216,128$76.17 —$— \n\nMarch 1 - March 31, 202641,062$73.94 —$— \n\nTotal260,194$75.92 —\n\n(1)Shares purchased during the period were transferred to the Company from employees in satisfaction of minimum tax withholding obligations associated with the vesting of restricted stock awards during the period."}